Clinical Trials Browser

Bile Duct Neoplasms × cabozantinib × Gastrointestinal × Clear all

NCT01954745 2017-02-03

Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma

Phase 2 Completed

19 enrolled 8 charts

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma